The present invention provides a hybrid biocompatible carrier (hybridosome) which comprises structural and bioactive elements originating from at least one biocompatible delivery module (BDM) and at least one engineered drug encapsulation module (EDEM) comprising at least one tunable fusogenic moiety. The invention further provides pharmaceutical compositions comprising said hybridosomes, processes for their manufacture, as well as pharmaceutical uses and pharmaceutical methods based thereon.
本发明提供了一种混合
生物相容性载体(杂交体),它包括来自至少一个
生物相容性递送模块(B
DM)和至少一个工程化药物封装模块(ED
EM)的结构和
生物活性元素,后者包含至少一个可调谐的致熔分子。本发明进一步提供了包含所述杂交体的药物组合物、其制造工艺以及基于其的药物用途和制药方法。